A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection.
about
Outer membrane vesicles as platform vaccine technologyDevelopment of Burkholderia mallei and pseudomallei vaccinesCharacterization of the Burkholderia mallei tonB Mutant and Its Potential as a Backbone Strain for Vaccine DevelopmentMelioidosis vaccines: a systematic review and appraisal of the potential to exploit biodefense vaccines for public health purposesProtection from hemolytic uremic syndrome by eyedrop vaccination with modified enterohemorrhagic E. coli outer membrane vesiclesA Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis.Melioidosis: Clinical impact and public health threat in the tropics.Production of a recombinant vaccine candidate against Burkholderia pseudomallei exploiting the bacterial N-glycosylation machinery.Evaluation of a Burkholderia pseudomallei Outer Membrane Vesicle Vaccine in Nonhuman PrimatesBurkholderia pseudomallei penetrates the brain via destruction of the olfactory and trigeminal nerves: implications for the pathogenesis of neurological melioidosis.Improved production process for native outer membrane vesicle vaccine against Neisseria meningitidis.A gold nanoparticle-linked glycoconjugate vaccine against Burkholderia mallei.Burkholderia vaccines: are we moving forward?Proteomic analysis and immunogenicity of Mannheimia haemolytica vesicles.New technologies in developing recombinant attenuated Salmonella vaccine vectors.Immunoproteomics: the key to discovery of new vaccine antigens against bacterial respiratory infections.Glycoengineered Outer Membrane Vesicles: A Novel Platform for Bacterial VaccinesImmunogenicity of mycobacterial vesicles in humans: identification of a new tuberculosis antibody biomarker.Evaluation of a protective effect of in ovo delivered Campylobacter jejuni OMVs.Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine.Comparative Burkholderia pseudomallei natural history virulence studies using an aerosol murine model of infection.Isolation of Chlamydia trachomatis and membrane vesicles derived from host and bacteria.Immune modulation by bacterial outer membrane vesicles.Melioidosis and glanders modulation of the innate immune system: barriers to current and future vaccine approaches.Cell membrane-derived nanomaterials for biomedical applications.Recent Advances in Burkholderia mallei and B. pseudomallei Research.Outer membrane vesicles derived from Salmonella Typhimurium mutants with truncated LPS induce cross-protective immune responses against infection of Salmonella enterica serovars in the mouse model.Efficacy of post exposure administration of doxycycline in a murine model of inhalational melioidosisA Burkholderia pseudomallei Outer Membrane Vesicle Vaccine Provides Cross Protection against Inhalational Glanders in Mice and Non-Human Primates.Development of Subunit Vaccines that Provide High Level Protection and Sterilizing Immunity Against Acute Inhalational Melioidosis.Identification and characterization of serovar-independent immunogens in Actinobacillus pleuropneumoniae.Outer Membrane Vesicle Vaccines from Biosafe Surrogates Prevent Acute Lethal Glanders in Mice.IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal Salmonella Develop at Discordant Rates.
P2860
Q26766539-330DF93C-FD34-4708-9CE0-15DB8E4E3185Q26861271-30162078-8F6D-4BCB-8EE1-85C38FBCEAA2Q27304432-EE729699-96C1-4701-98BA-3353C51C43E5Q27305733-27054941-051C-4C9E-8621-7018096500F8Q33416476-7E2D2DD0-83C2-47C2-AA6F-CA86D93A538EQ33601907-AD8AC767-E3CA-4DA1-8589-D4BD0DBBC367Q33663333-3192FAB8-566E-4046-85DF-FCEFBD32BE9BQ33965527-092829D9-BF7D-4570-8275-7109D979BFD5Q34081215-201CC501-F453-4DC3-8587-9B7F167F1248Q34415370-51E189F4-CB33-40CE-810C-360361CEEC1AQ34761285-044EE961-147A-4CA6-8CB8-ABA2D833756FQ35088366-04D96444-295C-4F90-ADD7-6E843974851BQ36587103-B641BDC2-41B2-4C89-86B6-B9DA04EA76F1Q36606754-A188B4CE-E192-44F4-9E10-A30C54B3C93EQ36653379-93457C99-ECE3-426E-9CAE-BC44CBA3D01DQ36676050-E5045DFD-58AD-430A-B702-CF997E81853EQ36823959-443EDF91-4323-40C8-AC18-DAAB35165EDEQ36927153-2CA9B616-8736-44C9-9DA8-E25A4782A228Q37280943-055E18EF-2121-42D6-810B-452DA2528F85Q37336008-236DDB26-D8F9-4298-A18C-7C3B28AC328AQ37623675-91127A73-A5D2-4780-B7FC-41AFA60AA1EAQ37848114-C7236347-3104-46FE-A006-B06AE8DCD5BBQ38481554-53DAE094-4CB2-42A8-82B9-F3EAC3469CF1Q38890754-4C99AA19-CB1A-4906-90B8-17679AA16C1DQ39178313-C222A950-C5F1-4680-B18E-0B7B475CB88FQ39970602-0FED6550-D599-4FAE-885B-0C909A1E39C5Q40557181-F621AA88-14F9-417C-87FD-D0642BB78F86Q42037524-56DC5776-7639-4C0A-93B8-E0CEED547F25Q46242885-B4F0D04F-1D5C-451F-A756-CF2DE8B4D08BQ47130468-FDDC2198-6D11-44A2-909B-57F8006D0426Q47139186-98BE3B0D-F1FD-4D94-9B87-0E3B3FBA5EA3Q48270562-12DA2F2D-97D5-4217-96FE-4340F78C5738Q52365266-31C5E176-457C-4C84-BC0B-A106A9892831
P2860
A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A naturally derived outer-memb ...... lderia pseudomallei infection.
@ast
A naturally derived outer-memb ...... lderia pseudomallei infection.
@en
type
label
A naturally derived outer-memb ...... lderia pseudomallei infection.
@ast
A naturally derived outer-memb ...... lderia pseudomallei infection.
@en
prefLabel
A naturally derived outer-memb ...... lderia pseudomallei infection.
@ast
A naturally derived outer-memb ...... lderia pseudomallei infection.
@en
P2093
P2860
P1433
P1476
A naturally derived outer-memb ...... lderia pseudomallei infection.
@en
P2093
Chad J Roy
James B McLachlan
Jonathan Kurtz
Katherine A Brown
Lisa A Morici
Saja Asakrah
Wildaliz Nieves
P2860
P304
P356
10.1016/J.VACCINE.2011.08.058
P407
P577
2011-08-24T00:00:00Z